If insulin can’t get out of blood vessels, it can’t act in its target tissues. “Endothelial cells are full of insulin ...
News Medical on MSN1d
Adrenomedullin hormone as key driver of insulin resistance in obesity-linked type 2 diabetesResearchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.
Functional subpopulations of β-cells emerge to control pulsative insulin secretion in the pancreatic islets of mice through calcium oscillations.
Several studies have shown that insulin-producing pancreatic β-cells of patients with diabetes have abnormal mitochondria and ...
News Medical on MSN5d
A pathway that contributes to insulin resistance can be targeted, mouse study showsThe hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study. Blocking ...
A study confirms the positive effects of exercise on insulin signaling proteins in the brain. A study led by researchers ...
A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...
Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...
The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 ...
A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...
Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback